Autopsy report · NCT06381830

Clinical Study of CAR-T Cell Therapy Following ASCT for R/R B-cell Non-Hodgkin's Lymphoma

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“The study was terminated due to changes in national policy.”

The sponsor’s own words in the registry.

Life of this trial

Registered 4 months after it had already started.
Ran for about 2 years 3 months before it stopped.
8 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: The First Affiliated Hospital of Soochow University
Sponsor type: University, hospital or other
Conditions: Lymphoma, B-Cell; Autologous Stem Cell Transplantation
Interventions: Apheresis; Autologous Stem Cell Transplantation; CAR-T Cell Therapy
Participants: 8
Sites: 1
Countries: China

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.